Eli Lilly to buy biopharmaceutical firm Dermira for $1.1bn

This article was originally published here

Based in Menlo Park of California, Dermira is involved in the development of novel therapies to treat patients with chronic skin conditions. As per terms of the deal,

The post Eli Lilly to buy biopharmaceutical firm Dermira for $1.1bn appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply